Product Information

GNP DUAL ACTION PAIN 250-125 MG is a generic product labeled by AmerisourceBergen, priced at $0.0899 per EA under NDC 46122081861. Its NADAC has been published 40 times since Sep 24, 2025.

GNP DUAL ACTION PAIN 250-125 MG

Acetaminophen and Ibuprofen
$0.0899per EA
OTC

Strength

250; 125 mg/1; mg/1

Manufacturer

AmerisourceBergen

NDC

46122081861

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ACETAMINOPHEN; IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA216999

On Market Since

5/15/2025

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for GNP DUAL ACTION PAIN 250-125 MG has been published 40 times since Sep 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0899 per EA
All-time high$0.0965 (Nov 12, 2025)
All-time low$0.0839 (Apr 22, 2026)
52-week high$0.0965
52-week low$0.0839
Median price$0.0900
Average price$0.0899
Largest weekly change+8.2% (Oct 22, 2025)
Weeks tracked40
Tracking sinceSep 24, 2025

Price History

1W

0.0%

1M

+6.6%

3M

+2.0%

6M

-2.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.9%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GNP DUAL ACTION PAIN 250-125 MG?

The current National Average Drug Acquisition Cost (NADAC) for GNP DUAL ACTION PAIN 250-125 MG, manufactured by AmerisourceBergen, is $0.0899 per EA (NDC 46122081861), effective Jun 24, 2026.

How has the price of GNP DUAL ACTION PAIN 250-125 MG changed over time?

Over the history we have for it, the NADAC for GNP DUAL ACTION PAIN 250-125 MG has held within roughly two percent of its current level. It has been tracked across 40 weekly CMS publications since Sep 24, 2025.

What are the highest and lowest recorded NADAC prices for GNP DUAL ACTION PAIN 250-125 MG?

Since Sep 24, 2025, the NADAC for GNP DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0839 (Apr 22, 2026) to a high of $0.0965 (Nov 12, 2025), with a median of $0.0900 per EA.

Are there cheaper alternatives to GNP DUAL ACTION PAIN 250-125 MG?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, is $0.0844 per EA — about 6% below GNP DUAL ACTION PAIN 250-125 MG.

Who manufactures GNP DUAL ACTION PAIN 250-125 MG?

GNP DUAL ACTION PAIN 250-125 MG (NDC 46122081861) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.